LAURUSLABS

HealthcareDrug Manufacturers - Specialty & GenericLarge Cap
Laurus Labs Limited

Laurus Labs Limited operates in the Healthcare sector, specifically in Drug Manufacturers - Specialty & Generic. The company manufactures and sells medicines, active pharmaceutical...

हिन्दी में

लॉरस लैब्स लिमिटेड स्वास्थ्य सेवा क्षेत्र में कार्यरत है, विशेष रूप से ड्रग मैन्युफैक्चरर्स - स्पेशलिटी और जेनेरिक उप-क्षेत्र में। कंपनी भारत और अंतरराष्ट्रीय स्तर पर दवाएं, सक्रिय...

₹2,036.6+1.94%1D
Previous trading day close · Data updates after market close
1W: +3.3%
1M: +5.1%
6M: +87.2%
1Y: +135.9%
51/100
Below AvgResearch Score
Market Cap
₹78.5K Cr
Large Cap
P/E Ratio
93.75
Premium
P/B Ratio
15.34
Premium
ROE
17.7%
Decent
ROCE
19.7%
Excellent
Debt / Equity
0.46
Low debt
Div. Yield
0.1%
EV/EBITDA
46.85
Expensive
52W Low: ₹843Current: ₹2,036.652W High: ₹2,065.2
At 98% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
78/100
Growth
Revenue, EPS, profit growth
40/100
Valuation
PE, PB, EV/EBITDA vs sector
15/100
Risk
Debt levels, volatility, coverage
67/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
93.75(Premium)
Forward P/E
77.58(Premium)
P/B Ratio
15.34(Premium)
P/S Ratio
12.13(Expensive)
EV/EBITDA
46.85(Expensive)
Dividend Yield
0.1%
5Y CAGR
17.9%(High growth)
Revenue Growth
22.0%(High)
Profitability
ROE
17.7%(Good)
ROCE
19.7%(Excellent)
ROA
9.0%(Average)
Net Margin
12.9%(Decent)
EBITDA Margin
26.7%
Financial Health
Debt to Equity
0.46(Low debt)
Current Ratio
1.33(Tight)
Quick Ratio
0.68(Tight)
Interest Coverage
7.92x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
62(Neutral)
RSI Exp (14)
56(Neutral)
MACD
39.152(Bullish)
MACD Signal
42.354
BB Position
78%(Middle)
BB Width
8.25%(Normal)
ADX (14)
30.8(Strong trend)
Williams %R
-25.3(Neutral)
MFI (14)
59(Neutral)
CCI (20)
75(Neutral)
Stoch %K
75(Neutral)
ATR (14)
49.86(Avg True Range)
OBV (M)
200.5(Positive)
1W OBV Chg
1.1%(Increasing)
Rel Volume
0.57x(Normal)
Volatility
33.4%(Moderate)
Max DD 1Y
-18.7%(Resilient)
EMA 200
1473.3
EMA 50
1883.4
SMA 200
1381.1
vs SMA 50
6.8%(Above SMA50)
vs SMA 200
47.5%(Above SMA200)
Volume
13.58L
Avg Vol 3M
23.8L
Shareholding Pattern
Promoter
27.5%
Low stake
FII
25.8%
Strong foreign interest
DII / MF
14.0%
Share LAURUSLABS
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.